HAN advisory over drug-resistant typhoid cases

The CDC is investigating nine cases of extensively-resistant (XDR) typhoid fever in US residents who had no history of travel (eight were from 2020). Surveillance of the strain was initiated in 2018 and since then, 71 cases have been recorded – 58 involved travel to Pakistan in the preceding 30 days. The HAN report also noted that an ‘unrelated cluster of ceftriaxone-resistant Typhi infections linked to Iraq has been reported in the United States and the United Kingdom’. 

Advice for travellers

Typhoid fever is endemic in many developing regions, although it generally presents a low risk for short-stay travellers staying in western-style accommodation. Vaccination is itinerary specific, but is usually recommended for those staying or travelling extensively in rural areas, as well as for adventurous eaters and for travel to areas reporting drug-resistant typhoid. All travellers visiting endemic areas should follow safe food and water guidelines, and adopt strict personal hygiene practices. Read more about typhoid fever.

Before you travel, call Travelvax Australia’s telephone advisory service on 1300 360 164 (toll-free from landlines) for country-specific advice and information. You can also make an appointment at your nearest Travelvax clinic to obtain vaccinations, medication to prevent or treat illness, and accessories for your journey.